Caxton Associates (New York)’s Vicor VICR Stock Holding History
Bought
Maintained
Sold
Other funds holding VICR
BCM
FAM
NIM
Caxton Associates (New York)'s VICR Position: Q2 2023 in Review
Caxton Associates (New York) sold out of Vicor (VICR) in Q2 2023, closing a stake of 7,148 shares — an estimated $336K sold.
Caxton Associates (New York) first reported a position in VICR in Q1 2019 and held it in 3 quarters. The position peaked at $1.53M in Q1 2019. 200 funds tracked by Wall St. Rank hold VICR as of Q2 2023.
- Caxton Associates (New York) reported no remaining Vicor position as of Q2 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 7,148 Vicor shares in Q2 2023, an estimated $336K.
- Caxton Associates (New York) first reported a position in Vicor in Q1 2019 and held it in 3 quarters.
- Caxton Associates (New York)'s Vicor position peaked at $1.53M in Q1 2019.
- 200 funds tracked by Wall St. Rank held Vicor as of Q2 2023.
Based on Caxton Associates (New York)'s 13F filing for Q2 2023, filed 15 Aug 2023.